Skip to main content

Table 2 Changes in lipid profile after 24 weeks of therapy

From: Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial

  AP (n = 71) PL (n = 70)
Baseline 24 weeks Baseline 24 weeks
Tot-C (mg/dL) 224 ± 45 211 ± 44* 218 ± 38 221 ± 40
LDL-C (mg/dL) 133 ± 36 119 ± 33* 128 ± 29 130 ± 32
NHDL-C (mg/dL) 174 ± 42 158 ± 41* 168 ± 36 171 ± 39
HDL-C (mg/dL) 51 ± 11 53 ± 13* 50 ± 12 50 ± 10
TG (mg/dL) 151 ± 82 142 ± 93§ 160 ± 87 164 ± 100
  1. * = p < 0.01 ARM vs Placebo. § = p < 0.05 24 weeks vs Baseline